Smith Group Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-364
Closed -$7K 510
2015
Q3
$7K Buy
+364
New +$7K ﹤0.01% 355